NY High Court Lets Biotronik Pursue Recall-Related Damages
New York's highest court ruled Thursday that stent reseller Biotronik AG's alleged $100 million in lost profits from a distribution contract that soured after a manufacturer's recall qualify as general damages...To view the full article, register now.
Already a subscriber? Click here to view full article